Credit Suisse Ag Innoviva, Inc. Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Innoviva, Inc. stock. As of the latest transaction made, Credit Suisse Ag holds 125,154 shares of INVA stock, worth $2.44 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

125,154

Previous 128,292 2.45%

Holding current value

$2.44 Million

Previous $2.06 Million 7.29%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$14.56 - $16.78 $45,689 - $52,655	-3,138 Reduced 2.45%	125,154 $1.91 Million
Q4 2023 Feb 08, 2024	SELL	$12.32 - $16.27 $74,733 - $98,693	-6,066 Reduced 4.51%	128,292 $2.06 Million
Q3 2023 Nov 13, 2023	BUY	$12.37 - $13.89 $42,552 - $47,781	3,440 Added 2.63%	134,358 $1.75 Million
Q2 2023 Aug 11, 2023	BUY	$11.39 - $13.72 $324,239 - $390,567	28,467 Added 27.79%	130,918 $1.67 Million
Q1 2023 May 10, 2023	BUY	$10.73 - $13.6 $43,789 - $55,501	4,081 Added 4.15%	102,451 $1.15 Million
Q4 2022 Feb 13, 2023	BUY	$11.8 - $13.78 $103,981 - $121,429	8,812 Added 9.84%	98,370 $1.3 Million
Q3 2022 Nov 10, 2022	BUY	$11.61 - $15.22 $61,393 - $80,483	5,288 Added 6.28%	89,558 $1.04 Million
Q2 2022 Aug 12, 2022	BUY	$14.32 - $19.88 $47,528 - $65,981	3,319 Added 4.1%	84,270 $1.24 Million
Q1 2022 May 16, 2022	BUY	$15.39 - $20.25 $9,911 - $13,041	644 Added 0.8%	80,951 $1.57 Million
Q4 2021 Feb 14, 2022	SELL	$15.91 - $18.72 $338,151 - $397,874	-21,254 Reduced 20.93%	80,307 $1.38 Million
Q3 2021 Nov 12, 2021	SELL	$13.06 - $17.24 $68,917 - $90,975	-5,277 Reduced 4.94%	101,561 $1.7 Million
Q2 2021 Aug 16, 2021	BUY	$11.45 - $13.96 $281,315 - $342,983	24,569 Added 29.86%	106,838 $1.43 Million
Q1 2021 May 14, 2021	SELL	$11.06 - $12.87 $355,081 - $413,191	-32,105 Reduced 28.07%	82,269 $984,000
Q4 2020 Feb 12, 2021	BUY	$9.33 - $12.48 $204,728 - $273,848	21,943 Added 23.74%	114,374 $1.42 Million
Q3 2020 Nov 13, 2020	SELL	$10.33 - $14.49 $410,245 - $575,455	-39,714 Reduced 30.05%	92,431 $965,000
Q2 2020 Aug 12, 2020	BUY	$11.49 - $15.26 $177,187 - $235,324	15,421 Added 13.21%	132,145 $1.85 Million
Q1 2020 May 13, 2020	BUY	$8.11 - $15.23 $478,262 - $898,143	58,972 Added 102.11%	116,724 $1.37 Million
Q4 2019 Feb 12, 2020	SELL	$10.28 - $14.38 $168,663 - $235,932	-16,407 Reduced 22.12%	57,752 $818,000
Q3 2019 Nov 12, 2019	BUY	$10.05 - $14.55 $296,515 - $429,283	29,504 Added 66.07%	74,159 $781,000
Q2 2019 Aug 14, 2019	SELL	$13.1 - $14.95 $440,120 - $502,275	-33,597 Reduced 42.93%	44,655 $650,000
Q1 2019 May 14, 2019	SELL	$13.69 - $20.06 $540,166 - $791,507	-39,457 Reduced 33.52%	78,252 $1.1 Million
Q4 2018 Feb 13, 2019	BUY	$13.96 - $18.26 $189,786 - $248,244	13,595 Added 13.06%	117,709 $2.05 Million
Q3 2018 Nov 13, 2018	SELL	$13.63 - $15.7 $90,339 - $104,059	-6,628 Reduced 5.99%	104,114 $1.59 Million
Q2 2018 Aug 14, 2018	SELL	$13.44 - $17.59 $134,453 - $175,970	-10,004 Reduced 8.29%	110,742 $1.53 Million
Q1 2018 May 15, 2018	BUY	$13.8 - $16.99 $80,937 - $99,646	5,865 Added 5.11%	120,746 $2.01 Million
Q4 2017 Feb 14, 2018	SELL	$11.73 - $14.75 $77,523 - $97,482	-6,609 Reduced 5.44%	114,881 $1.63 Million
Q3 2017 Nov 14, 2017	BUY	$12.06 - $14.12 $555,399 - $650,268	46,053 Added 61.05%	121,490 $1.72 Million
Q2 2017 Aug 14, 2017	BUY	N/A	75,437	75,437 $965,000

Others Institutions Holding INVA

# of Institutions

222

Shares Held

79.7M

Call Options Held

20K

Put Options Held

5.4K

View Full List

About Innoviva, Inc.

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.36B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

More about INVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account